Edingen-Neckarhausen, Germany

Thomas Hoeger


Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas Hoeger: Innovator in Pharmaceutical Chemistry

Introduction

Thomas Hoeger is a prominent inventor based in Edingen-Neckarhausen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for various biological processes. With a total of 3 patents to his name, Hoeger continues to push the boundaries of innovation in his field.

Latest Patents

Among his latest patents, one notable invention is related to heterocyclic compounds and their use as PARP inhibitors. This invention focuses on compounds of a specific formula and their tautomeric forms, as well as possible enantiomeric and diasteromeric forms, including prodrugs. Another significant patent involves cyclo-alkyl substituted benzimidazoles, which also serve as PARP inhibitors. These inventions highlight Hoeger's commitment to advancing therapeutic options in medicine.

Career Highlights

Thomas Hoeger is currently employed at Abbott GmbH & Co. KG, a leading company in the healthcare sector. His work at Abbott has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

Some of his notable coworkers include Michael Kock and Roland Grandel. Their collaborative efforts have further enhanced the innovative environment at Abbott, leading to the development of new and effective pharmaceutical solutions.

Conclusion

In summary, Thomas Hoeger is a dedicated inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His patents reflect a deep understanding of complex chemical compounds and their potential applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…